Alternative splicing: An important regulatory mechanism in colorectal carcinoma

Mol Carcinog. 2021 Apr;60(4):279-293. doi: 10.1002/mc.23291. Epub 2021 Feb 25.

Abstract

Alternative splicing (AS) is a process that produces various mRNA splicing isoforms via different splicing patterns of mRNA precursors (pre-mRNAs). AS is the primary mechanism for increasing the types and quantities of proteins to improve biodiversity and influence multiple biological processes, including chromatin modification, signal transduction, and protein expression. It has been reported that AS is involved in the tumorigenesis and development of colorectal carcinoma (CRC). In this review, we delineate the concept, types, regulatory processes, and technical advances of AS and focus on the role of AS in CRC initiation, progression, treatment, and prognosis. This summary of the current knowledge about AS will contribute to our understanding of CRC initiation and development. This study will help in the discovery of novel biomarkers and therapeutic targets for CRC prognosis and treatment.

Keywords: alternative splicing; colorectal carcinoma; regulation mechanism.

Publication types

  • Review

MeSH terms

  • Alternative Splicing*
  • Biomarkers, Tumor / genetics*
  • Colorectal Neoplasms / genetics*
  • Disease Progression
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Prognosis

Substances

  • Biomarkers, Tumor